Insider Trends: McKesson Insider Extends 90-Day Selling Trend
06:20 PM EDT, 05/11/2021 (MT Newswires) -- Dr Brian Scott Tyler, Director and CEO, on May 10, 2021, sold 6,798 shares in McKesson (MCK) for $1,359,600. Dr Tyler has control over 12,404 company shares of which 12,192 shares are controlled directly and 212 shares indirectly subsequent to the transactions detailed in the SEC Form 4 filing. These holdings have an approximate market value of $2.51 million as of the prior-day closing price.
In the 90 days previous to the date of this filing, there have been 6 insider transactions reported to the SEC for McKesson. These transactions came from the activity of one insider that resulted in no change to insider holdings with acquisitions exactly offset by dispositions of company shares. In the preceding 90-day window of time, there were 8 transactions from 5 insiders and resulted in the net disposition of 1,802 shares.
This is lower than the average level of insider transactions in the 13-company Drug Retailers peer group over the last 90-day period. Activity in the peer group averaged 106.8 transactions per company, with company insiders acquiring on average 154,919 shares.
SEC Story Link http://www.sec.gov/Archives/edgar/data/927653/000159810021000009/xslF345X03/edgar.xml
This report does not constitute a recommendation to purchase or sell any security and the analysts are not registered investment advisors. Further analysis is recommended before undertaking any position in any security. Any risks are solely the responsibility of the buyer/seller. The authors, publishers and distributors of the MT Newswires Live Briefs service and any associates thereof accept no liability for the content or actions taken by anyone or institution utilizing this report.